Judge Bans Andrx, Ranbaxy Generic Versions Of Biaxin
The latest development in the drawn-out litigation will prevent the companies, for now, from marketing their generic versions of the popular drug in the United States.
Florida-based Ranbaxy, and its India-based parent Ranbaxy Pharmaceuticals Ltd., sued Abbott in December 2004, seeking declaratory judgment of non-infringement of five Biaxin patents. Six months later, Abbot sued Andrx, seeking declaratory judgment of infringement of...
To view the full article, register now.